Delivery Order SPE2DR25D2101-SPE2DR26F47UL
Award Date 1/28/26
Potential Completion Date 1/29/26
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,854.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mitomycin 20 mg vials, with an ultimate completion date of December 17, 2025. This is an unset-aside, competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, serving as a primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,200.06 for 40 mg vials of Mitomycin, a chemotherapy medication commonly used in oncology treatment. The contract was awarded on November 26, 2025, with an ultimate completion date of November 28, 2025, and utilizes firm fixed pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,667.25 firm fixed-price contract is for the provision of 40 mg vials of the drug mitomycin, a chemotherapy medication. The contract has an ultimate completion date of May 8, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $7.2K to AmerisourceBergen Drug Corp for the supply of Mitomycin 40 mg vials. This firm fixed-price contract, which was competitively awarded without a set-aside designation, is scheduled for completion by December 19, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under a larger contract vehicle supporting federal pharmaceutical procurement...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,956,675 units of the pharmaceutical product Mitomycin 20 mg vials. The $1,100.72 contract has a performance period through March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00...
- This is a delivery order (Contract #SPE2DB20D1100 | SPE2DB24FD9D4) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 5 mg Mitomycin vials. The award is valued at $2,977.68 and has a firm-fixed price. The contract has an ultimate completion date of September 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Mitomycin 5 mg vials to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,818.90 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 11, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency awarded a $29,449.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 21, 2026, for the supply of Mylotarg 4.5 mg vials, with completion scheduled for February 11, 2026. This competitively awarded contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $27,081.44 for Mylotarg 4.5 mg vials under a Defense Logistics Agency contract with the Medical Supply Chain. The award, made on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a firm fixed price, competitively awarded delivery against an existing contract vehicle. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order does not...
- The Defense Logistics Agency awarded a $8,173.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 microgram vials of dactinomycin, an antitumor antibiotic used in cancer chemotherapy. The award, made on December 4, 2025, with an ultimate completion date of December 5, 2025, is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate headquarters in...